Cyclin D1 and CDK6, as the other two important regulators in cell cycle and cell proliferation [30–32], have been demonstrated to be highly expressed in prostate cancer and have enormous potential in wide various of cancer research and prognosis judgement [33–36]. Here, CDK6 is linked to prostate cancer.